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Increasing evidence suggests that ion channels and pumps not only regulate membrane
potential, ion homeostasis, and electric signaling in excitable cells but also play important
roles in cell proliferation, migration, apoptosis and differentiation. Consistent with a role
in cell signaling, channel proteins and ion pumps can form macromolecular complexes
with growth factors, and cell adhesion and other signaling molecules. And while cancer
is still not being cataloged as a channelopathy, as the non-traditional roles of ion pumps
and channels are being recognized, it is increasingly being suggested that ion channels
and ion pumps contribute to cancer progression. Cancer cell migration requires the
regulation of adhesion complexes between migrating cells and surrounding extracellular
matrix (ECM) proteins. Cell movement along solid surfaces requires a sequence of cell
protrusions and retractions that mainly depend on regulation of the actin cytoskeleton
along with contribution of microtubules and molecular motor proteins such as mysoin.
This process is triggered and modulated by a combination of environmental signals,
which are sensed and integrated by membrane receptors, including integrins and
cadherins. Membrane receptors transduce these signals into downstream signaling
pathways, often involving the Rho GTPase protein family. These pathways regulate the
cytoskeletal rearrangements necessary for proper timing of adhesion, contraction and
detachment of cells in order to find their way through extracellular spaces. Migration and
adhesion involve continuous modulation of cell motility, shape and volume, in which ion
channels and pumps play major roles. Research on cancer cells suggests that certain
ion channels may be involved in aberrant tumor growth and channel inhibitors often lead
to growth arrest. This review will describe recent research into the role of ion pumps
and ion channels in cell migration and adhesion, and how they may contribute to tumor
development.
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Introduction
Cancer is a leading cause of death worldwide. According to the American Cancer Society, more
than 1.6 million new cases were diagnosed in 2013, and one in four deaths in the US is cancer
related. Most cancers are treated with surgery, chemotherapy, and/or radiation therapy. Although
these clinical measures have proven their efficacy in many cases, patients often experience
debilitating side effects that significantly reduce their quality of life. Moreover, cancer relapse
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with treatment resistance underscores the urgent need to
identify novel molecular targets for the development of
alternative therapies. Recently, the role of ion channels in
driving malignant cancer cell behavior has been revealed
and much has been learned from brain tumors (Figure 1).
Changes in channel expression have been observed primarily
in glioblastoma, the most aggressive malignant brain tumor
arising from astrocytes (Sontheimer, 2008) and have also
been seen in medulloblastoma, the most common pediatric
brain tumor that originates in the cerebellum (Hatten and
Roussel, 2011). With our increasing knowledge of ion
channels and pumps in tumor development cancer is being
classified as a channelopathy, or a disease brought about by
disturbed function of ion channels, often due to dysregulation
of channel expression (transcriptional channelopathy) or
other modifications resulting in altered function (Pedersen
and Stock, 2013; Djamgoz et al., 2014) (and articles
therein).
The proteins that transport ions across cell membranes fall
into two general classes: ion channels, through which ions
move down their concentration and electrical gradients, and
ion pumps that use energy to actively move ions against
those gradients (Gadsby, 2009). About 13% of currently known
drugs whose primary therapeutic targets are ion channels
are being used for the treatment of a variety of human
conditions, including cardiovascular and neurological disorders
(Overington et al., 2006). Some examples include lidocaine, a
local anesthetic that targets sodium channels, verapamil, a drug
used to treat hypertension and targets calcium channels, riluzole
which is used to treat amyotrophic lateral sclerosis and targets
sodium channels, and the class of drugs that target sodium
channels in the brain to treat epilepsy such as carbamazepine
and topiramate (Camerino et al., 2007). With our evolving
understanding of the molecular mechanisms of channelopathies,
ion channels have now become a promising player for the
development of novel anticancer therapies. In this review we
will discuss a variety of classes of channels and pumps and their
relationship to cancer development and progression including
sodium, potassium, chloride, and calcium channels, and ion
transport pumps.
Overview of Ion Channels and Pumps with
Dysregulated Expression in Cancer Cells
Potassium Channels
Potassium channels can be divided into four classes based on
their domain structure and activation mechanisms. Voltage-
gated potassium channels (Kv) are the largest subset of
potassium channels, and they are gated by changes in
membrane potential. Calcium-activated potassium channels
(KCa) are activated by intracellular calcium. According to
their conductance, KCa channels can be further divided into
big conductance (BK), intermediate conductance (IK), and
small conductance (SK) channels. KV and KCa channels share
a similar structure---they are composed of four pore-lining
α-subunits, each with six transmembrane domains and one
pore-forming region, except for the BK channel, which has
FIGURE 1 | Cancer as a channelopathy. Mutations, loss of
expression/function and aberrant expression/function of ion channels and
transporters have been linked to various cancers. Aberrant cell migration, cell
adhesion, and cell cycle control all contribute to the invasive phenotype
associated with metastasis.
one additional transmembrane segment in the N terminus.
Transmembrane regions 1--4 represent the voltage-sensing
domains for Kv channels (Huang and Jan, 2014). Inward
rectifying potassium channels (Kir) possess two transmembrane
segments flanking one pore loop in each of the four α-subunits.
Two-pore domain potassium channels (K2P) have two pore
domains per α-subunit. Two α-subunits form a K2P channel
that is usually constitutively open as a ‘‘leak channel’’ for
maintaining a negative membrane potential (Huang and Jan,
2014). Multiple studies have reported dysregulated potassium
channel expression in human cancer. Overexpression of KV1.1
is seen in medulloblastoma (Northcott et al., 2012), elevated
KV1.3 can be detected in multiple malignancies including
breast, colon, and prostate cancer (Comes et al., 2013), and
overexpression of a specific splice variant of the BK channel
correlates with the malignancy grade of glioma (Liu et al.,
2002). Altered expression of the intermediate-conductance
calcium activated channel KCa3.1 has also been shown
in glioblastoma (Catacuzzeno et al., 2012). KV1.5 channels
are dysregulated in multiple cancers including lymphomas,
astrocytomas, oligodendrogliomas, and glioblastomas (Comes
et al., 2014). Expression levels of KV10.1 (EAG1, voltage gated
eag related subfamily H, member 1) are lower in glioblastoma
multiforme and in malignant brain tumors than in normal
brain tissue, and expression of the EAG1 channel is inversely
related to malignancy of the tumor (Patt et al., 2004). Human
ether-a-go-go related gene (hERG) K+ channel, also known
as KV11.1, is constitutively expressed in neuroblastoma, and a
molecular complex between β1-integrins and hERG channels
regulates adhesion-dependent differentiation of neuroblastoma
cells (Cherubini et al., 2005). And expression of Kir4.1
channels in glioma cells impaired cell growth (Higashimori and
Sontheimer, 2007).
Sodium Channels and Exchangers
Voltage gated sodium channels (VGSCs) are responsible for
the rising phase of the action potential in the majority of
electrically excitable cells and are therefore important in impulse
generation and propagation. VGSCs comprise a multi-gene
family of at least nine different functional members (NaV1.1--1.9)
coding for the pore-forming α-subunits. There are also four
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auxiliary β-subunits, of which one or two at a time can
associate with an α-subunit and modulate channel expression
and activity in the plasma membrane. Recently, VGSCs have
been found to have relatively high expression levels in a
range of cell types that are considered non excitable, including
immune cells, fibroblasts and cancer cells (Brackenbury, 2012).
Moreover, several individual NaV isoforms are differentially
expressed in different human cancers. These include NaV1.5
in astrocytoma, breast and colon cancers (Chioni et al., 2010;
Brisson et al., 2013; Driffort et al., 2014; Xing et al., 2014),
NaV1.6 in cervical cancer, and NaV1.7 in breast, prostate and
non-small cell lung cancers (Fraser et al., 2014). Another
group of sodium channels is the epithelial sodium channel
family, located in the apical membrane of polarized epithelial
cells. High grade gliomas express multiple members of the
epithelial sodium channel family, and there is an elevated
expression of the acid-sensing ion channel 1 (ASIC1) in
glioblastoma cells compared to primary astrocytes (Kapoor et al.,
2009).
In addition to these sodium channel families, there is
also a group of exchanger proteins that involve transport of
sodium ions. Some of these exchanger proteins include the
Na+/H+ exchanger (NHE1), the Na+, HCO−3 contransporter,
and the Na+, K+, 2Cl− cotransporter (NKCC). All of these
proteins utilize the Na+ electrochemical gradient to drive
the transport of other ions, and they are all important
in maintaining cellular pH. The NHE1 is a ubiquitously
expressed transporter that contributes to cell volume regulation
and cytoplasmic pH homeostasis. In cancer NHE1 is
upregulated and/or overexpressed in various tumors and
plays a fundamental role in malignant invasion by altering
the metabolic environment and cell invasiveness (Cardone
et al., 2005; Stock et al., 2012). For example, NHE is involved
in breast cancer and melanoma invasion and metastasis
(Stüwe et al., 2007; Amith and Fliegel, 2013; Vahle et al.,
2014) indicating that NHE1 may be a suitable target for
anticancer therapy (Stock et al., 2012). Aside from NHE1,
additional exchangers have been shown to be affected in
cancer. For example, the Na+/HCO−3 contransporter is
upregulated by human epidermal growth factor receptor
2 (HER2) signaling in breast cancer cells (Gorbatenko et al.,
2014), and NKCC modulates glioma cell migration through
regulation of focal adhesions and cell volume (Garzon-Muvdi
et al., 2012).
Chloride Channels
The CLC and the cystic fibrosis transmembrane conductance
regulator (CFTR) channels are distinct classes of chloride
channels. Functions of chloride channels range from ion
homeostasis to cell volume regulation and regulation of excitable
cells. These channels have 10--12 transmembrane domains, and
are found both in the plasma membrane and the membranes
of various organelles. Dysregulation of chloride channels has
been reported in multiple cancer types. Expression of CLCA1
and CLCA2 is downregulated in human colorectal cancer,
revealing a possible tumor suppressor role for these proteins
(Bustin et al., 2001). Changes in glioma-specific chloride
current are linked to the cell cytoskeleton, and cytoskeletal
rearrangements associated with cell division lead to change in
chloride channel activity (Ullrich and Sontheimer, 1997), and
regulate glioblastoma cell invasiveness (Turner and Sontheimer,
2014).
Calcium Channels
Ca2+ is a ubiquitous second messenger, and is an important
signaling molecule for several fundamental cell processes
including cell cycle control, migration, and apoptosis. Some
human diseases that have been associated with Ca2+ homeostasis
include cancer, Alzheimer’s disease, and cardiovascular disease
(Chen et al., 2013). Regulation of intracellular Ca2+ involves
both Ca2+ entry from the extracellular space and Ca2+ release
from intracellular stores in the endoplasmic reticulum (ER)
or mitochondria. Calcium channels not only allow facilitated
diffusion of Ca2+ down its concentration gradient, they also
provide for the flow of Ca2+ out of the ER into the cell cytosol
through ER Ca2+ channels. Plasmamembrane channels involved
in the influx of Ca2+ into the cell include voltage-gated Ca2+
and transient receptor potential (TRP) ion channels. There
are multiple types of calcium channels that are differentially
regulated in various cancer types. TRPC3 is elevated in some
breast and ovarian tumors, and its silencing reduces ovarian
cancer cell line proliferation in vitro and tumor formation in
vivo (Aydar et al., 2009). TRPC6 expression is elevated in breast,
liver, and stomach cancers and in glioma. Silencing of TRPC6
reduces proliferation of some esophageal and breast cancer
cell lines and glioma cells (Ding et al., 2010). The expression
level of TRPM7 and formation of metastases are positively
correlated in breast cancer, suggesting that TRPM7 contributes
to a migratory and invasive phenotype. T-type voltage gated
Ca2+ channels are expressed in normal tissues as well as
in various cancers such as breast carcinoma, retinoblastoma,
neuroblastoma, and glioma (Zhang et al., 2014). Increased
expression of the α1 subunit of T-type channels contributes to
abnormal proliferation of glioblastoma cells, siRNA-mediated
knockdown of the α1 subunit decreases proliferation of these
cells, and pharmacological blockade of T-type channels decreases
tumor growth (Zhang et al., 2014).
Ion Exchangers
The P-type ATPases are a major class of ion pumps and
are characterized by an aspartate residue in the cytoplasmic
domain that gets phosphorylated by ATP once transported
ions have entered the binding pocket (Gadsby, 2009). Some
examples of P-type ATPases are the Sodium potassium ATPase
(Na,K-ATPase), the sarcoplasmic and endoplasmic reticulum
Ca-ATPase (SERCA), the H,K-ATPase and the H-ATPase. To
date, the best characterized pumps that have been linked to
cancer are SERCA and the Na,K-ATPase. SERCA ATPases
are important regulators of intracellular calcium concentration.
They enable muscle contraction and relaxation, and control
calcium signaling pathways (Yatime et al., 2009). SERCA also
has recently been identified as a therapeutic target in certain
types of cancer. SERCA inhibition induces a G0/G1 arrest in
NOTCH1-mutated human leukemia cells, introducing SERCA
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as a potential therapeutic target in cancers associated with
NOTCH1 mutations (Roti et al., 2013). SERCA inhibition
through a thapsigargin prodrug is being tested as a potential
treatment for prostate cancer by inducing apoptosis (Denmeade
et al., 2003). The Na,K-ATPase is a ubiquitously expressed
integral membrane protein that carries out the extrusion and
uptake of Na+ and K+ ions across the plasma membranes of
cells of most higher eukaryotes. It is composed of a catalytic
α-subunit with ten transmembrane segments and a heavily
glycosylated β-subunit. The pump is critical in maintaining
a physiological electrochemical gradient that is essential for
cell survival and for many cellular activities. Na,K-ATPase is
highly expressed in glioblastoma cells (Mijatovic et al., 2008).
Decreased expression of Na,K-ATPase β1-subunit has also been
reported in various cancers (Rajasekaran et al., 1999, 2001;
Espineda et al., 2003, 2004; Seligson et al., 2008; Rajasekaran
and Rajasekaran, 2009). The effect of the Na,K-ATPase has
also been studied in glioblastoma cells. Treatment with digoxin
and ouabain, both specific Na,K-ATPase inhibitors, resulted in
impaired proliferation in glioblastoma cell lines and the same
cells exhibited an apoptotic phenotype (Joshi et al., 2011). Along
with the identification of its differential expression in cancer cells
and its important roles in cell survival, proliferation, adhesion
and migration, the clinical potential of Na,K-ATPase modulators
such as cardiac glycosides in oncology has drawn increasing
interest in recent years (Newman et al., 2008; Prassas and
Diamandis, 2008; Menger et al., 2012; Alevizopoulos et al., 2014;
Wolle et al., 2014).
Ion Carriers, Ion Channels and Ion Pumps in
Cancer Cell Migration
Ion channels and pumps are the targets of many intracellular
signaling pathways and can function as signal transducers
themselves. Nearly every type of voltage-gated K+, Ca2+, and
Na+ channel is regulated to some extent by phosphorylation of
serine, threonine, or tyrosine residues on intracellular domains
of the channel (Ismailov and Benos, 1995). Phosphorylation can
alter channel gating properties, including voltage sensitivity
and calcium sensitivity, thereby potentially altering the
electrophysiological properties of a cell. While initially only
studied in excitable cells, ion channels are now known to be
important in supporting the basic biology of malignant and
non-malignant cells including cell proliferation and tumor cell
migration. The ability of cancer cells to migrate allows them to
change position within the body and invade other tissues. As a
primary tumor grows, it must undergo angiogenesis in order to
support its metabolic needs. New blood vessels can also provide
a route by which tumor cells can migrate through the body’s
circulatory system, into a distant organ or tissue (Chambers
et al., 2002). Tumor cells use migration mechanisms that are
similar, if not identical to those in normal cells during normal
physiological processes such as embryogenesis, wound healing,
and neuronal migration. Migration requires cells to modify
their shape and stiffness to interact with surrounding tissue, and
results from a continuous cycle of interdependent steps. First, a
moving cell becomes polarized, and, through Rac activation, a
protrusion of the lamellipodium is formed at the cell’s leading
edge, which attaches to the extracellular matrix (ECM). Next,
regions of the cell body contract, generating a force that leads
to movement of the cell (Schwartz and Horwitz, 2006). Invasive
cancer cells develop similar invadopodia to explore and invade
the surrounding ECM. Both the outgrowth of lamellipodia or
invadopodia and the retraction of the rear end of the cell require
local swelling and shrinkage, respectively. These changes in
cell volume are regulated by local ion transport through the
NHE1, the Na+, HCO−3 contransporter, the Na+, K+,2Cl−
cotransporter, chloride channels at the leading edge and tip of
the outgrowing lamellipodium/invadopodium (Schwab et al.,
1999; Stroka et al., 2014; Turner and Sontheimer, 2014). In
breast cancer cells, repetitive cycles of local, NHE1-dependent
swelling at the cell front and shrinkage at the rear end enable cells
to move independently of actin polymerization and integrin-
mediated adhesion. This may be the mechanism underlying
the rounded tumor cell migration that allows cell movement
through dense ECM without matrix degradation (Friedl and
Alexander, 2011).
Potassium Channels
The best characterized functions of potassium channels in
facilitating cell migration are related to their ability to cause
volume changes by affecting potassium flow (see (Turner and
Sontheimer, 2014) for a comprehensive review). An early study
linking potassium channels to cell migration was on transformed
Madin-Darby canine kidney (MDCK-F) renal epithelial cell
migration. The authors showed that specific application of the
IK channel blocker charybdotoxin to the trailing edge, but
not the leading edge, inhibits migration and increases overall
cell volume (Schwab et al., 1999). Their results revealed that
inhibition and activation of the IK channel elicited nearly
identical effects on migration, F-actin content and intracellular
calcium concentration as anisosmotic cell swelling or shrinkage.
Since IK channel inhibition or activation elicits similar volume
changes as anisotonicity, the authors suggested that cell volume
is a link between K+ channel activity, the actin cytoskeleton and
migration (Schwab et al., 1999). More recent studies showed
that genetic suppression or pharmacological inhibition of BK
channels impairs glioma cell migration. Specifically, Weaver
et al. (2006) found that inhibition of BK channels reduced
glioma cell migration across a transwell filter, suggesting that
K+ efflux is essential for glioma cell migration. Interestingly,
chronic application of a BK channel opener also resulted in
impaired glioma cell migration, demonstrating the importance of
controlling potassium channel activity for proper cell movement
(Kraft et al., 2003). Another important potassium channel
involved with cell migration is KCa3.1 (Sciaccaluga et al., 2010;
Catacuzzeno et al., 2011, 2012), an IK channel involved in
retraction of the cell’s trailing edge for forward movement
(Schwab et al., 2012). Inhibition of KCa3.1 disrupts glioma cell
chemotaxis towards multiple ligands (Cuddapah et al., 2013).
Moreover Clotrimazole, a KCa3.1 channel blocker inhibits the
growth of glioblastoma cells by arresting cells at the G1-S
transition, and delays development of intracranial glioblastoma
tumor formation (Liu et al., 2010). The SK channel was shown
to control constitutive Ca2+ entry and cancer cell migration
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through interaction with the Ca2+ channel Ora1 in lipid rafts.
Localization of the SK-Ora1 complex was essential to control
cancer cell migration, and co-localization of the two channels
was found in primary human tumors and bone metastases
(Chantôme et al., 2013). Potassium channels can also regulate
cancer cell migration via non-canonical functions. For example,
the KV11.1 (HERG) channel can form a macromolecular
complex with vascular endothelial growth factor receptor
(VEGFR)-1 and β1-integrin, and assembly of this complex
confers a pro-migratory phenotype in leukemia (Pillozzi et al.,
2002). Colocalization of α9β1 integrin with the Kir4.2 channel
in focal adhesions at the leading edge of migrating cells can
promote local Kir4.2 channel activity to induce formation of
a lamellipodium extension for migration. Moreover, the Kir
channel inhibitor barium, or knockdown of the subunit Kir4.2,
specifically inhibited α9-dependent cell migration (deHart et al.,
2008; Schwab and Stock, 2014).
Sodium Channels
Expression of VGSCs has been associated with cell motility and
metastatic behavior. Grimes et al. (1995) found that the strongly
metastatic Mat-LyLu cell line expressed VGSCs, while the related
but weakly metastatic AT-2 cell line did not. Interestingly,
incubation of theMat-Ly-Lu cell line with tetrodotoxin, a specific
VGSC blocker, reduced the invasive capacity of the cells in
vitro. A similar pattern was found in analogous human prostate
cancer cell lines PC-3 and human prostate adenocarcinoma
(LNCaP), respectively (Laniado et al., 1997). Both NaV1.6 and
NaV1.7 were significantly upregulated in prostate cancer cell
lines (Shan et al., 2014). In vitro experiments have also shown
that tetrodotoxin inhibits cancer invasion, proliferation and
migration in PC-3 prostate cancer cells (Shan et al., 2014). More
specifically, the effects of VGSC α- and β-subunit expression
individually have been researched in various cancers. Expression
of the VGSC α-subunit has been reported in several cancers
including breast cancer, prostate cancer, neuroblastoma, and
glioma (Brackenbury, 2012). In some of these malignancies, α-
subunit protein andmRNA expression correlated withmetastatic
potential. For example, VGSC was found to increase in line with
metastatic potential in the LNCaP progression model of prostate
cancer cells (Bennett et al., 2004). Conversely, in gliomas, the
mRNA level of VGSC α-subunits is inversely correlated with
malignancy grade (Schrey et al., 2002). The role of VGSC β-
subunits has also been investigated. The β1-subunit is highly
expressed in weakly metastatic breast cancer (MCF-7) cells, and
it enhances adhesion while inhibiting migration in a transwell
assay (Chioni et al., 2009). On the other hand, much lower levels
of β1 were found in strongly metastatic breast cancer MDA-MB-
231 cells. Overexpression of β1 in these cells increased cell-cell
adhesion, induced process outgrowth, and reduced migration
in wound healing assays (Chioni et al., 2009). Overexpression
of β2 in LNCaP cells increased adhesion, process outgrowth,
migration, and invasion (Jansson et al., 2012). Thus, it seems
that β1 and β2 play slightly different functional roles in different
cancer cells. It is important to note that β-subunits play a critical
role in regulating adhesion and migration in excitable cells like
neurons, where they are normally expressed. For example, β1
enhances neurite outgrowth and neuronal path finding during
early postnatal development of the central nervous system
(Davis et al., 2004). β1-mediated neurite outgrowth in cerebellar
granule cells requires fyn kinase, the cell adhesion molecule
contactin, and is dependent on NaV1.6 activity (Brackenbury
et al., 2008).
Chloride Channels
Chloride channels are critical in maintaining cell volume, and
therefore play an important role in regulating migration of
cancer cells. Migratory glioma cells are elongated, suggesting
that invading glioma cells undergo cell volume changes to move
through the extracellular space (Sontheimer, 2004). Blocking
Cl− channels inhibits changes in cell volume and inhibits
cell migration (Watkins and Sontheimer, 2011). Inhibition
of NKCC1, which maintains an outward gradient for Cl−,
also impairs motility of glioma cells in vitro (Haas and
Sontheimer, 2010). Non-specific Cl− channel inhibitors decrease
cell migration in vitro (Soroceanu et al., 1999). However more
specifically, shRNA mediated knockdown of ClC-3 decreased in
vitro glioma cell migration (Cuddapah and Sontheimer, 2010)
and Chlorotoxin, which reduces membrane expression of ClC-3,
inhibited migration in vitro and in vivo (Sontheimer, 2008).
Calcium Channels
Changes in intracellular Ca2+ concentrations play an important
role in cancer cell migration and tumor metastasis, and multiple
Ca2+ channels have been linked to cancer cell migration.
Inhibition of the TRPM7 channel resulted in reversal of
epidermal growth factor (EGF)-induced migration of a lung
cancer cell line and inhibited basal migration of the cells in
the absence of EGF (Gao et al., 2011). High levels of TRPM7
expression predicted poor outcome in breast cancer patients and
was functionally required for metastasis in a mouse xenograft
model of human breast cancer (Middelbeek et al., 2012).
Inhibition of TRPC6 activity showed reduced glioma cell growth,
G2 phase cell cycle arrest, and reduced growth of subcutaneously
and intracranially implanted gliomas, as well as increased
survival of mice in vivo (Ding et al., 2010). Another study
involving TRPC6 revealed that TRPC6 knockdown inhibited
glioma cell invasion and angiogenesis, and they concluded that
TRPC6 is required for development of the aggressive glioma
phenotype (Chigurupati et al., 2010). Like NHE1 or NCKK,
TRPC1 channels were localized to lipid raft domains at the
leading edge of migrating glioma cells, and shRNA-mediated
TRPC1 knockdown resulted in loss of EGF-induced glioma cell
migration (Bomben et al., 2011).
Ion Pumps
The Na,K-ATPase has been linked to cancer cell motility and
migration in vitro. Repletion of Na,K-ATPase β1-subunit in
Maloney Sarcoma virus transformed MDCK (MSV-MDCK)
cells induced lamellipodia and suppressed motility in a
phosphatidylinositol 3-kinase (PI3-kinase) dependent manner,
and protein kinase C was involved upstream of PI3-kinase
in the suppression of β1-subunit mediated cell motility in
carcinoma cells (Rajasekaran et al., 2001; Barwe et al.,
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2005, 2006). The Na,K-ATPase α1-subunit associated with the
regulatory subunit of PI3-kinase and β1-subunit bound to
anexin II, and these molecular interactions localized activated
PI3-kinase at lamellipodia and suppressed cell motility in
MSV-MDCK cells, independent of Na,K-ATPase ion transport
activity (Barwe et al., 2005). Changes in Na,K-ATPase subunit
expression were also found in various other cancers (Rajasekaran
et al., 1999; Espineda et al., 2003; Lefranc et al., 2008;
Mijatovic et al., 2008; Seligson et al., 2008; Rajasekaran
and Rajasekaran, 2009). Ouabain, an Na,K-ATPase inhibitor,
inhibited EGF induced medulloblastoma cell motility in a
wound healing assay, prevented formation of EGF-induced
actin stress fibers, and inhibited EGF-induced phospho-focal
adhesion kinase (FAK) localization to the lamellipodia of
medulloblastoma cells (Wolle et al., 2014). The Na,K-ATPase
β2-subunit has also been linked to cancer cell motility,
specifically in glioblastoma multiforme. Na,K-ATPase β2-
subunit expression inhibits invasion of glioblastoma multiforme
cells, and its downregulation increases invasion in glial cells
(Sun et al., 2013). Another group found that inhibition
or down regulation of Na,K-ATPase induced a cell death
with characteristics of both apoptosis and necrosis, and
disruption of K+ homeostasis was important in induction
of apoptosis in human glioblastoma cells (Chen et al.,
2014).
Ion Channels and Cell Signaling
There is increasing evidence that ion channels can form signaling
complexes with cell adhesion proteins including integrins.
Integrins are a family of membrane-spanning glycoproteins
that link ECM to the cytoskeleton. They are composed of α-β
heterodimers with extracellular domains that bind ECM proteins
and short cytoplasmic tails that associate with focal adhesion
proteins. Integrins form signaling complexes at cell adhesion
sites with other membrane receptors. Adaptor proteins such
as Cas, Crk, and paxillin contribute to formation of adhesive
complexes, which comprise focal adhesions. Downstream
signaling pathways are then triggered by several enzymes
including focal adhesion kinasse (FAK), the tyrosine kinase Src,
and GTPases such as Ras and Rho (Brown, 2002). Evidence
suggests that cellular processes that require activation of adhesion
proteins such as cell differentiation, neurite extension and
migration depend on ion channel activity. Multiple studies
have demonstrated the crosstalk between ion channels and
cell adhesion molecules. One of the first studies to reveal the
formation of macromolecular complexes between integrins and
ion channels came when McPhee et al. (1998) found that
the G protein-gated inwardly rectifying K+ channels (GIRKs)
contain an Arginine-Glycine-Aspartate (RGD) sequence on their
extracellular loop. RGD sequences mediate interaction between
ECM proteins and integrins and are absent on the extracellular
side of other K+ channels. Further evidence showed that β1
integrin associates with the Na,K-ATPase and voltage gated Ca2+
channels (Shakibaei and Mobasheri, 2003). In PC12 cells, the
shift to a neuronal phenotype induced by neural cell adhesion
molecules and N-cadherins is mediated by Ca2+ channels
(Doherty et al., 1991). Integrins were observed to regulate neurite
extension in neuroblastoma cells by activating K+ channels
(Arcangeli et al., 1993).
Ion pumps can also activate cellular signaling pathways. For
example, in addition to its ion pumping function, Na,K-ATPase
can also act as a signal transducer. When cells are exposed
to drugs known to be specific inhibitors of Na,K-ATPase
(such as ouabain, digoxin, and digitoxin), multiple intracellular
signaling pathways are activated, including the Epidermal growth
factor receptor (EGFR)/Src-Ras-Erk pathway and the PI3K-
PDK-Akt pathway (Pierre and Xie, 2006; Reinhard et al., 2013).
Ouabain can activate the Ras and Erk signaling pathways. Src
is necessary for ouabain-induced activation of the EGFR/Ras-
Erk pathway, and activation of PI3-kinase and Akt by ouabain
leads to fibroblast cell proliferation (Wu et al., 2013). As
mentioned earlier, the Na,K-ATPase β1-subunit suppresses cell
motility by cross talk between the two subunits of Na,K-ATPase
with the PI3-kinase signaling pathway (Barwe et al., 2005).
However, inmedulloblastoma cells, ouabain did not transactivate
EGFR as has been reported in other cell lines, and ouabain
inhibited EGF-induced Erk1/2 and Akt activation (Wolle et al.,
2014).
Ion Channels, Proliferation and the Cell Cycle
During development, tissues grow by proliferation, with some
cell types able to divide throughout life. Cell proliferation is
highly regulated in order to assure proper coordination of cell
number. Cancer cells divide and proliferate faster than normal
cells, resulting in tumor development. A role for ion channels
in cell proliferation has been found in multiple cell types and
cancers. Studies have found that some ion channel blockers also
inhibit cell cycle progression and arrest cells at distinct stages of
the cell cycle (Becchetti, 2011). For example, different potassium
channels show cell-cycle-dependent variations in expression and
activity (Pardo et al., 1998). Potassium channel blockers and
depolarizing agents inhibit cell proliferation in oligodendrocyte
progenitors in cell culture and cerebellar tissue slices by inducing
G1 arrest through accumulation of p27 and p21, two cyclin
dependent kinase (CDK) inhibitors involved in cell proliferation
(Ghiani et al., 1999). Inhibition of the voltage gated K+ channels
KV1.3 and KV1.5 decreased proliferation of glioma cells (Pardo,
2004). For the KV1.3 channel, this affect on cell proliferation
was due to interaction with the signaling adaptor protein
14-3-3 (Rajan et al., 2002). Also, inhibition of ATP-sensitive
K+ channels (KATP) decreased proliferation in vitro and slowed
tumor formation in xenografts, with cells arrested at G0/G1
phase of the cell cycle (Huang et al., 2009). Knockdown of
Kir2.2 induced a significant increase in reactive oxygen species
accompanied by cell cycle arrest. Moreover, pre-established
tumors reduced in size after injection of siRNA targeting Kir2.2
(Lee et al., 2010). EAG channels are involved in cell cycle control,
and inhibition of EAG expression in multiple cancer cell lines
leads to reduction in cell proliferation (Pardo et al., 1999).
Kir4.1 is also an important channel in regulating cell division
(Turner and Sontheimer, 2014). Blocking the Kir4.1 channel in
astrocytes induced proliferation, while overexpression in glioma
cells arrested proliferation (Higashimori and Sontheimer, 2007).
A role of BK channels in glioblastoma proliferation has been
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suggested (Chin et al., 1997; Wang, 2004). BK channel inhibition
arrests glioma cells in S phase of the cell cycle, and causes a
dose and time dependent decrease in cell number as early as
72 h after exposure (Weaver et al., 2004). Nevertheless, other
groups suggested that some of the inhibitors of BK channels
may regulate cell proliferation through off-target mechanisms
(Abdullaev et al., 2010).
Calcium signaling also plays an important role in regulation
of the cell cycle. Cells progressing from G1 to S require both
extracellular calcium and functional membrane calcium channels
in order to activate downstream signaling (Taylor et al., 2008).
Partial inhibition of plasma membrane Ca2+ ATPase (PMCA)
mediated calcium efflux reduced proliferation of MCF-7 breast
cancer cells. An antisense construct directed towards PMCA
lead to changes in cell cycle control kinetics, with a prolonged
G2 phase that occurs with reduced Ca2+ efflux (Lee et al.,
2005). Knockdown of TRPC6 expression inhibits glioma growth,
invasion, and angiogenesis, and is an important mediator of
glioblastoma tumor growth in vitro and in vivo (Chigurupati
et al., 2010).
In addition, changes in sodium channels impact tumor cell
proliferation. For example, the nNaV1.5 channel, a neonatal form
of VGSC, was upregulated in human brain astrocytoma and
positively correlated with the degree ofmalignancy while reduced
nNaV1.5 expression significantly suppressed the proliferation of
astrocytoma cells (Xing et al., 2014). Thus, modulation of various
ion channels has profound effects on regulating cell cycle control
and proliferation of cancer cells.
Therapeutic Potential
Most cancers are treated by surgical resection, chemotherapy,
and radiation therapy. However due to the prevalence of cancer
relapse with treatment resistance, novel molecular targets must
be identified for the development of alternative therapies. Despite
the growing evidence of aberrant expression and function of
ion channels in oncology, development of cancer treatment
using ion channel targeting compounds is still at an early
stage. Studies have shown that some VGSC blockers can
inhibit cell behaviors associated with metastasis. For example,
the anticonvulsant phenytoin suppressed migration of prostate
cancer cells (Fraser et al., 2003), and also inhibited migration
and invasion in metastatic breast cancer cells (Yang et al.,
2012). Riluzole, which is both a VGSC blocker and metabotropic
glutamate receptor inhibitor, reduced the breast cancer tumor
volume in mice, and suppressed metabolic activity of tumors
in patients with stage III and IV melanoma (Yip et al.,
2009). The KV10.1 EAG1 channel has been closely studied
as a target for cancer therapy, since EAG1 overexpression
is associated with tumorigenic potential, and its expression
is correlated with poor patient survival in multiple cancer
types (Pardo and Stühmer, 2008). The small molecule EAG1
blocker astemizole reduced EAG1-expressing cancer cell growth
in vitro and in vivo (Downie et al., 2008). A highly specific
extracellular epitope-targeting EAG1 monoclonal antibody
exhibited antitumor activity in a mouse model (Gómez-Varela
et al., 2007). T-type Ca2+ channels have also been suggested as a
potential therapeutic target for certain brain tumors. Mibefradil,
a calcium channel inhibitor, was found to inhibit proliferation
in human glioma and neuroblastoma cells, and overexpression
of T-type Ca2+ channel protein doubled the proliferation rate
while antisense treatment reduced the proliferation rate of
these cells (Panner et al., 2005). The Na,K-ATPase is another
potential target for cancer therapy. Human glioblastoma cells
that are resistant to the chemotherapy drug temozolomide
(TMZ) show a higher expression of Na,K-ATPase α2- and α3-
subunits compared to TMZ-sensitive cells and astrocytes. These
cells were also sensitive to ouabain at low concentrations, and
knockdown of the α3-subunit sensitized the cells to TMZ (Chen
et al., 2014). Judging from the large number of ion channels
that are altered in cancers, it is clear that understanding more
about ion channels and pumps and how they contribute to
cancer progression could reveal new therapeutic targets for many
different cancers. The findings discussed above provide proof
of principle that ion channels are effective targets for cancer
therapy.
Conclusions
Increasing evidence suggests that ion channels and pumps are
involved in the regulation of cell proliferation and migration,
and channel proteins have been shown to form macromolecular
complexes with cell adhesion molecules and other signaling
proteins. As these roles of ion channels and pumps are
further elucidated, it is being increasingly suggested that
regulation of ion channels and pumps could contribute to
cancer progression. Here we discussed that aberrant expression
and function of several types of ion channels and pumps
have been found in multiple cancers including brain cancer,
and in particular, glioblastoma. Knowing that these proteins
are involved in multiple malignant characteristics of multiple
cancers, ion channels and pumps could be potential targets for
therapy.
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